JERSEY CITY, N.J., Oct. 20, 2017 --
Bel Fuse Inc. (“Bel,” or, “the Company”) (NASDAQ:BELFA) (NASDAQ:BELFB), a leading supplier of products that power, protect and connect electronic circuits, today announced that the Company will release preliminary financial results for the third quarter of 2017 prior to the commencement of trading on Friday, November 3, 2017. A conference call has been scheduled for 11:00 a.m. ET that morning to discuss the preliminary results.
To participate in the conference call, investors should dial 1-888-259-8544 or 1-719-457-2630 if dialing internationally. The presentation will additionally be broadcast live over the Internet and will be available at the Events and Presentations link of the Investors page under the “About Bel” tab at www.BelFuse.com. The webcast will be available via replay for a period of 20 days at this same Internet address. For those unable to access the live call, a telephone replay will be available at 1-844-512-2921 or 1-412-317-6671 if dialing internationally, using access code 7129850 after 2:00 p.m. ET, also for 20 days.
About Bel
Bel (www.belfuse.com) designs, manufactures and markets a broad array of products that power, protect and connect electronic circuits. These products are primarily used in the networking, telecommunications, computing, military, aerospace, transportation and broadcasting industries. Bel's product groups include Magnetic Solutions (integrated connector modules, power transformers, power inductors and discrete components), Power Solutions and Protection (front-end, board-mount and industrial power products, module products and circuit protection), and Connectivity Solutions (expanded beam fiber optic, copper-based, RF and RJ connectors and cable assemblies). The Company operates facilities around the world.
| Investor Contact: Peter Seltzberg, Managing Director Darrow Associates tel 516.419.9915 [email protected] | Company Contact: Daniel Bernstein President [email protected] |


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 



